Developer of precision medicine in oncology designed to provide big data analysis in cancer. The company develops a cell-free liquid biopsy technology, enabling healthcare professionals to use minimally-invasive molecular diagnosis for treatment selection, therapy monitoring, and detection of cancer earlier.
Developer of precision medicine technologies designed to address unmet needs in immune-mediated and inflammatory diseases. The company offers features such as a proprietary data analytics engine that harmonizes extensive patient molecular profiles, identifies novel therapeutic targets, and develops diagnostics, enabling researchers and healthcare providers to create targeted therapies based on individual genetics, ultimately improving treatment outcomes for patients suffering from chronic conditions.
Developer of healthcare utilization management technology designed to help manage the total cost of cancer care. The company's technology offers access to current, evidence-based, disease-specific insights on all cancer types and treatment options, backed by board-certified oncology physicians and pharmacists, thereby enabling healthcare organizations to provide their patients with the ability to achieve reliable outcomes through affordable and optimal treatment.